Sign Up Today and Learn More About Vitara Biomedical Stock
Invest in or calculate the value of your shares in Vitara Biomedical or other pre-IPO companies through EquityZen's platform.
Vitara Biomedical Stock
Vitara Biomedical developed a therapeutic platform to support premature infants.
About Vitara Biomedical Stock
Founded
2019
Headquarters
Philadelphia, PA, US
Industries
Vitara Biomedical Press Mentions
Stay in the know about the latest news on Vitara Biomedical
Wall Street Journal: University City-based BioTech Firm Nears Human Trials for Breakthrough Artificial Womb Technology
vista • Feb 10, 2024
Artificial Wombs for Premature Babies Might Soon Begin ...
smithsonianmag • Dec 20, 2023
US regulators may soon approve human trials of artificial wombs
theblaze • Dec 20, 2023
FDA to discuss initial human testing of artificial womb for babies
ktvq • Dec 20, 2023
Philly Money Moves: West Philadelphia Skills Initiative won a ...
technical • Dec 20, 2023
Vitara Biomedical Management
Leadership team at Vitara Biomedical
Chief Financial Officer
John B. Kelly
Founder, President & CEO
Jim McGlone
Join now and verify your accreditation status to gain access to:
- Vitara Biomedical current valuation
- Vitara Biomedical stock price
- Available deals in Vitara Biomedical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Vitara Biomedical stock?
Accredited investors can buy pre-IPO stock in companies like Vitara Biomedical through EquityZen funds. These investments are made available by existing Vitara Biomedical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vitara Biomedical stock?
Shareholders can sell their Vitara Biomedical stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
